3XU-48861-12315
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 199 / DE
- Registered
- 2021-08-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-18
Registered in v-safe
-
2021-08-18
Dose 1 — Moderna
- 2021-08-18
-
2021-08-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-08-20
- 2021-08-21
- 2021-08-22
-
2021-08-24
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: GoodFree text: Nose bleedsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Health check-in — day 7, dose 1Feeling: Good · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-09-03
- 2021-09-08
-
2021-09-15
Dose 2 — Moderna
- 2021-09-29
- 2021-10-06
- 2021-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-18 | Moderna | No |
| 2 | 2021-09-15 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Nose bleeds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Epistaxis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release